This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Northwestern University, Universidade Federal Do Rio De Janeiro. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,217 
1 out of 38 Years Active: 2003-2023
Title: Sergio Teixeira Ferreira: Patents in Alzheimer’s Disease and Amyloidosis
Introduction
Sergio Teixeira Ferreira is an inventor associated with Rio de Janeiro, Brazil. His work includes patent inventions focused on potential approaches to Alzheimer’s disease and amyloidosis. He is credited with 2 patents.
Latest Patents
One patent, “Compositions and Methods for Treating Alzheimer’s Disease,” describes antibodies targeting amyloid-beta (Aβ) oligomers and methods for their use in treating Alzheimer’s disease. It particularly presents neuronal expression of single-chain variable fragment (scFv) antibodies against Aβ oligomers as a therapeutic approach.
Another patent, “Methods for Inhibition and Dissolution of Amyloidoses by Administration of Compositions Comprising 2,4-Dinitrophenol,” concerns inhibiting the formation and development of amyloidoses and dissolving amyloid deposits in organisms. The supplied description also refers to diagnostic methods using aromatic and heteroaromatic compounds with at least one electron-withdrawing group.
Career Highlights
Ferreira’s listed institutional affiliations include Northwestern University and the Universidade Federal do Rio de Janeiro. The provided information does not specify his roles or dates of work at these institutions.
Collaborations
His listed collaborators include Paulo Roberto Ferreira Louzada, Jr. and Diana Jerusalinsky.
Conclusion
Sergio Teixeira Ferreira’s patent portfolio, as described here, centers on proposed therapeutic and diagnostic approaches to Alzheimer’s disease and amyloidosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile